Because of a lapse in government funding, the information on this website may not be up to date transactions submitted via the website may not be processed, and the agency may not be able to respond to inquiries until appropriations are enacted.

The NIH Clinical Center (the research hospital of NIH) is open. For more details about its operating status, please visit

Updates regarding government operating status and resumption of normal operations can be found at


  • Resize font
  • Print
  • Email
  • Facebook
  • Twitter
  • Google+
  • Pinterest
 (duh-BRA-feh-nib MEH-zih-layt)

This page contains brief information about dabrafenib and a collection of links to more information about the use of this drug, research results, and ongoing clinical trials.

US Brand Name(s)
FDA Approved

FDA Approval for Dabrafenib for Non-Small Cell Lung Cancer

FDA Approval for Dabrafenib for Melanoma

Use in Cancer

Dabrafenib is approved to be used alone or with trametinib to treat:

Dabrafenib is used only in patients whose cancer has a certain mutation in the BRAF gene.

Dabrafenib is also being studied in the treatment of other types of cancer.

More About Dabrafenib

Definition from the NCI Drug Dictionary - Detailed scientific definition and other names for this drug.

MedlinePlus Information on Dabrafenib - A lay language summary of important information about this drug that may include the following:

  • warnings about this drug,
  • what this drug is used for and how it is used,
  • what you should tell your doctor before using this drug,
  • what you should know about this drug before using it,
  • other drugs that may interact with this drug, and
  • possible side effects.

Drugs are often studied to find out if they can help treat or prevent conditions other than the ones they are approved for. This patient information sheet applies only to approved uses of the drug. However, much of the information may also apply to unapproved uses that are being studied.

Research Results and Related Resources

Two-Drug Combination Approved for Lung Cancers with BRAF Mutations

Combining Two Types of Targeted Therapy Improves Survival in Some Patients With Advanced Melanoma

New Therapies Are Changing the Outlook for Advanced Melanoma

Targeted Cancer Therapies

MEK: A Single Drug Target Shows Promise in Multiple Cancers

Clinical Trials Accepting Patients

Find Clinical Trials for Dabrafenib - Check for trials from NCI's list of cancer clinical trials now accepting patients.

  • Posted: June 21, 2013
  • Updated: July 20, 2017